All insights
Connected Care 6 min read August 10, 2026

From Test to Treatment: Building a Connected Diagnostic Care Pathway

In many consumer testing experiences, the healthcare workflow stops at exactly the moment the patient most needs help interpreting what happens next.

HealthCheck Editorial Team
Connected Care

Testing is often the beginning—not the end—of care

A patient purchases an at-home diagnostic product.

The test produces a result.

Then what?

In many consumer testing experiences, the healthcare workflow stops at exactly the moment the patient most needs help interpreting what happens next.

A test-to-treat model is designed to connect those steps.

What is test-to-treat?

Test-to-treat is an integrated care model in which diagnostic information can flow directly into an appropriate clinical evaluation and, when medically indicated, treatment.

A connected digital pathway may look like:

Test Activation → Result → Clinical Intake → Provider Review → Treatment Decision → eRx → Pharmacy → Follow-Up

The clinical evaluation remains essential.

A diagnostic result is typically one input among symptoms, history, medications, allergies and risk factors.

Why test-to-treat matters

At-home diagnostics dramatically improve convenience.

But convenience alone does not solve healthcare fragmentation.

Patients may still have to:

  • locate a provider
  • repeat their health information
  • explain which test they used
  • communicate the result
  • find a pharmacy
  • manage follow-up

A connected pathway can reduce those handoffs.

Step 1: Activate the diagnostic

A QR or Data Matrix code can identify the product and launch the correct workflow.

The system can capture information such as:

  • UUID
  • product
  • lot
  • expiration
  • test type

This creates traceability from the physical product into the digital care journey.

Step 2: Capture the result

Depending on the test, the result may be:

  • digitally transmitted
  • photographed
  • interpreted with supported computer vision
  • self-attested
  • reviewed by a clinician

Invalid or ambiguous results should branch into retesting or review rather than being treated as definitive.

Step 3: Add clinical context

The platform can collect information relevant to the specific clinical protocol.

For a urinary-health pathway, that might include:

  • symptoms
  • onset
  • severity
  • prior infections
  • medications
  • allergies
  • pregnancy possibility
  • red flags
  • STI or vaginal symptoms

This is where the diagnostic result becomes part of a broader clinical picture.

Step 4: Apply eligibility and safety gates

Not every patient should move into a simplified digital treatment pathway.

The workflow may identify situations requiring:

  • synchronous care
  • additional testing
  • in-person evaluation
  • urgent care
  • emergency escalation

The objective is to make digital access more convenient without ignoring clinical boundaries.

Step 5: Clinician evaluation

A licensed provider reviews the relevant information and determines whether treatment is appropriate.

The provider—not the test and not the AI system—makes the medical decision.

AI may help:

  • organize data
  • identify exceptions
  • surface protocol conflicts
  • flag risk factors
  • support workflow routing

But clinical authority remains with the treating professional.

Step 6: Electronic prescribing

If medication is clinically appropriate, the provider can create an electronic prescription through the clinical EHR.

The prescription can then be routed to the patient’s selected pharmacy.

Modern e-prescribing infrastructure makes this possible across broad retail pharmacy networks.

Step 7: Follow-up

The care pathway should not necessarily end when the prescription is sent.

Digital follow-up can evaluate:

  • symptom improvement
  • persistent symptoms
  • adverse reactions
  • recurrent symptoms
  • additional care needs

This helps close the loop.

Test-to-treat as infrastructure

The most important insight is that test-to-treat is not one feature.

It is an orchestration problem involving:

  • diagnostics
  • identity
  • clinical protocols
  • telehealth
  • EHR
  • pharmacy
  • notifications
  • support
  • analytics
  • compliance

HealthCloudOS and SafeCDx are designed to coordinate those layers through a common platform.

From product to healthcare access point

For consumer health companies, diagnostic manufacturers and retailers, test-to-treat creates a significant shift.

A product can become the entry point into a connected healthcare experience.

Instead of:

Buy → Test → Interpret Alone

the experience can become:

Buy → Test → Understand → Get Care → Treat → Follow Up

That is a fundamentally different consumer-health model.

Editorial note: This article is educational and does not provide medical, legal, coding, or reimbursement advice. Requirements change; verify the rules that apply to the specific service, patient, professional, payer, and jurisdiction.